N/A
Completed N=140
Syncope Prediction Study
Vasovagal Syncope
Source: ClinicalTrials.gov NCT02140567 ↗
Enrolled (actual)
140
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcomePrimary: Sensitivity of the Syncope Prediction Algorithm — 81; 2 Participants
Summary
The purpose of this study is to perform a prospective evaluation of the vasovagal syncope prediction algorithm, called Tilt Test Analyzer, during head up tilt testing tests in one center in the United Kingdom.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Sensitivity of the Syncope Prediction Algorithm |
81; 2 | — |
| PRIMARY Specificity of the Syncope Prediction Algorithm |
45; 6 | — |
Eligibility Criteria
Inclusion Criteria
- Patients referred to the center with vasovagal syncope for tilt testing.
- The patient is willing and able to cooperate with the study procedures.
- The subject or legal guardian is able to provide written informed consent
Exclusion Criteria
- Patients under 18 years or over 90 years old.
- Women who are currently pregnant or have a positive pregnancy test.
- Patients who had a prior tilt test.
- Patients enrolled in another device or drug study.
Data sourced from ClinicalTrials.gov (NCT02140567). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.